Peng Pan, Tao Wang, Masayoshi Nakashima

Development of Online Hybrid Testing (eBook, ePUB)

Theory and Applications to Structural Engineering

• Format: ePub

Produktbeschreibung

Development of Online Hybrid Testing: Theory and Applications to Structural Engineering provides comprehensive treatments of several topics pertinent to substructure online hybrid tests. Emphasis has been placed on explaining the three frameworks:

• the host-station framework,
• separated model framework and
• peer to peer framework

These have been developed within the Internet environment and are particularly suitable for distributed hybrid testing. In order to help readers to understand the essence of online hybrid testing and further to build up their own systems, an engineering practice has been introduced at the end of this book with the source code appended. Development of Online Hybrid Testing: Theory and Applications to Structural Engineering is primarily written for readers with some background in structural dynamics, finite elements, and computer science. Material that has previously only appeared in journal articles has been consolidated and simplified which provides the reader with a perspective of the state-of-the-art.

• Presents basics and implementations of time integration algorithms for online hybrid tests, along with the applications for real engineering projects
• Includes current progress on the development of substructure online hybrid tests as a means of investigating the seismic behaviour of large-scale structures
• Provides source code for the example tests

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Elsevier Science & Techn.
• Seitenzahl: 240
• Erscheinungstermin: 14. September 2015
• Englisch
• ISBN-13: 9780128033920
• Artikelnr.: 43851418

Autorenporträt

Dr. Wang obtained an MD from Norman Bethune University of Medical Sciences in China, a PhD in Toxicology from University of Louisiana, and is a Diplomat of the American Board of Toxicology. Dr. Wang's professional experience includes clinical practice in oncology, research on gene regulation in an academic setting, and more than 20 years of professional practice as toxicologist in the pharmaceutical/biotech industry. She is currently the Executive Director of Translational & Development Sciences at Coherus BioSciences, where she oversees preclinical development (in vivo pharmacokinetics, pharmacology and toxicology of small molecules and biologics) of drug candidates from early through late stage development. Prior to joining Coherus, Dr. Wang worked at Novartis Pharmaceuticals and Achaogen, where she led safety assessment efforts for oncology and non-oncology drug development. Dr. Wang received multiple professional awards, recognizing her significant achievements and performance above and beyond work requirements (e.g. Novartis Above & Beyond, Due Diligence, Catalyst Awards, and Spot Awards). She was also acknowledged for outstanding collaboration and contributions on multidisciplinary teams (e.g., Novartis Team Award). Dr. Wang is an active member with Society of Toxicology (SOT), and has contributed to the society's leadership team as a Councilor and by serving on numerous elected and appointed committees. She also served on the Board of Directors for the American Board of Toxicology (ABT) and is an advisor to the Education Committee at International Union of Toxicology (IUTOX). Dr. Wang is on the Editorial Boards of the International Journal of Toxicology and Toxicology Research and Application. Dr. Wang has taught a course on Practical Toxicology at the University of California at Berkeley as a guest lecturer.